FDA Biologics Inspections to Shrink in Trump Deregulation Push

April 10, 2019

President Donald Trump’s deregulation wave has swallowed another Food and Drug Administration (FDA) rule, one that requires agency inspectors to visit drug facilities creating expensive, complex products called biologics every other year.